Arabic Arabic English English French French German German
dark

Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer

 Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Evan Kearns as Chief Legal Officer. In his new role, Mr. Kearns will oversee all corporate legal operations for Cogent Biosciences. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

The Seven Stages of Alzheimer’s Disease Explained

Next Post

OneOncology Appoints Two New Board Members

Related Posts
Total
0
Share